116 related articles for article (PubMed ID: 21475312)
1. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
Kheirkhah A; Zavareh MK; Farzbod F; Mahbod M; Behrouz MJ
Eye (Lond); 2011 Jul; 25(7):872-80. PubMed ID: 21475312
[TBL] [Abstract][Full Text] [Related]
2. Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis.
Erdinest N; Noyman DBE; London N; Lavy I; Levinger N; Landau D; Solomon A; Morad Y; Naroo SA
Int Ophthalmol; 2024 Mar; 44(1):157. PubMed ID: 38522059
[TBL] [Abstract][Full Text] [Related]
3. Reserve drug as first-line management: Topical interferon α-2b for vernal keratoconjunctivitis.
Haral SR; Khan T; Gupta VS; Ukalkar MS
Indian J Ophthalmol; 2024 Jul; 72(7):1007-1011. PubMed ID: 38454855
[TBL] [Abstract][Full Text] [Related]
4. Management of vernal keratoconjunctivitis: Navigating a changing treatment landscape.
Ali A; Bielory L; Dotchin S; Hamel P; Strube YNJ; Koo EB
Surv Ophthalmol; 2024; 69(2):265-278. PubMed ID: 37890678
[TBL] [Abstract][Full Text] [Related]
5. A Patient-Centered Approach to Vernal Keratoconjunctivitis (VKC): A Podcast.
Larsen AC; Rasmussen MLR
Ophthalmol Ther; 2024 May; 13(5):1061-1069. PubMed ID: 38436902
[TBL] [Abstract][Full Text] [Related]
6. [New and future treatment approaches for allergic conjunctivitis].
Kassumeh S; Brunner BS; Priglinger SG; Messmer EM
Ophthalmologie; 2024 Mar; 121(3):180-186. PubMed ID: 38363381
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Clinical Outcome of Tacrolimus Skin Ointment (0.03%) for the Treatment of Vernal Keratoconjunctivitis: A Quasi-Experimental Study.
Ali W; Alam Khan S; Ullah Khan F; Khan S; Khan WA; Zafar R; Moqeet MA
Cureus; 2023 Dec; 15(12):e50579. PubMed ID: 38226116
[TBL] [Abstract][Full Text] [Related]
8. Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management.
Nibandhe A; Kaliki S; Jakati S; Shanbhag S; Basu S; Donthineni PR
Eye (Lond); 2024 May; 38(7):1320-1326. PubMed ID: 38155329
[TBL] [Abstract][Full Text] [Related]
9. Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators.
Hehar NK; Chigbu DI
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541686
[TBL] [Abstract][Full Text] [Related]
10. Allergic Reaction to Tropicamide Eye Drops: A Case Report.
Yelne S; Pendam M
Cureus; 2024 Apr; 16(4):e57945. PubMed ID: 38738153
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Autophagy in Conjunctival Fibroblasts.
Mehrbod P; Brun P; Rosani U; Leonardi A; Ghavami S
Methods Mol Biol; 2024 Mar; ():. PubMed ID: 38499918
[TBL] [Abstract][Full Text] [Related]
12. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
[TBL] [Abstract][Full Text] [Related]
13. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
Vichyanond P; Kosrirukvongs P
Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
[TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus 0.03% as sole therapy in vernal keratoconjunctivitis: a randomized double-masked study.
Müller GG; José NK; de Castro RS
Eye Contact Lens; 2014 Mar; 40(2):79-83. PubMed ID: 24418865
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.
Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H; Miyazaki D
Br J Ophthalmol; 2014 Aug; 98(8):1023-7. PubMed ID: 24695688
[TBL] [Abstract][Full Text] [Related]
16. [Follow-up study on patients with vernal keratoconjunctivitis undergoing topical 0.1% tacrolimus treatment].
Harada N; Inada N; Ishimori A; Shoji J; Sawa M
Nippon Ganka Gakkai Zasshi; 2014 Apr; 118(4):378-84. PubMed ID: 24864437
[TBL] [Abstract][Full Text] [Related]
17. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
Vichyanond P; Pacharn P; Pleyer U; Leonardi A
Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography assisted retinal nerve fibre layer thickness profile in high myopia.
Malakar M; Askari SN; Ashraf H; Waris A; Ahuja A; Asghar A
J Clin Diagn Res; 2015 Feb; 9(2):NC01-3. PubMed ID: 25859476
[TBL] [Abstract][Full Text] [Related]
19. Ocular Biometrics of Myopic Eyes With Narrow Angles.
Chong GT; Wen JC; Su DH; Stinnett S; Asrani S
J Glaucoma; 2016 Feb; 25(2):140-4. PubMed ID: 25836663
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
Pucci N; Caputo R; di Grande L; de Libero C; Mori F; Barni S; di Simone L; Calvani A; Rusconi F; Novembre E
Pediatr Allergy Immunol; 2015 May; 26(3):256-261. PubMed ID: 25712437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
